Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
API 31510 topical cream in SCCIS
NCT00652080Phase 2Completed
- Sponsor
- BPGbio
- Start
- Jun 2008
- Primary completion
- Jan 2010
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 2 trial of ubidecarenone nanodispersion in squamous cell carcinoma (SCC), sponsored by BPGbio. Started Jun 2008; status: completed.
02
Drugs
ubidecarenone nanodispersion
03
Conditions
squamous cell carcinoma (SCC)
Beyond the preview
Go deeper on NCT00652080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00652080.